Literature DB >> 15126339

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

Chris Jones1, Alan Mackay, Anita Grigoriadis, Antonio Cossu, Jorge S Reis-Filho, Laura Fulford, Tim Dexter, Susan Davies, Karen Bulmer, Emily Ford, Suzanne Parry, Mario Budroni, Giuseppe Palmieri, A Munro Neville, Michael J O'Hare, Sunil R Lakhani.   

Abstract

The normal duct-lobular system of the breast is lined by two epithelial cell types, inner luminal secretory cells and outer contractile myoepithelial cells. We have generated comprehensive expression profiles of the two normal cell types, using immunomagnetic cell separation and gene expression microarray analysis. The cell-type specificity was confirmed at the protein level by immunohistochemistry in normal breast tissue. New prognostic markers for survival were identified when the luminal- and myoepithelial-specific molecules were evaluated on breast tumor tissue microarrays. Nuclear expression of luminal epithelial marker galectin 3 correlated with a shorter overall survival in these patients, and the expression of SPARC (osteonectin), a myoepithelial marker, was an independent marker of poor prognosis in breast cancers as a whole. These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126339     DOI: 10.1158/0008-5472.can-03-2028

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  100 in total

1.  Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.

Authors:  Lixia Guo; Dominic Fan; Fahao Zhang; Janet E Price; Ju-Seog Lee; Dario Marchetti; Isaiah J Fidler; Robert R Langley
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

3.  Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.

Authors:  Tyler Risom; Xiaoyan Wang; Juan Liang; Xiaoli Zhang; Carl Pelz; Lydia G Campbell; Jenny Eng; Koei Chin; Caroline Farrington; Goutham Narla; Ellen M Langer; Xiao-Xin Sun; Yulong Su; Colin J Daniel; Mu-Shui Dai; Christiane V Löhr; Rosalie C Sears
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 4.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

Review 5.  Triple-negative breast cancer: disease entity or title of convenience?

Authors:  Lisa Carey; Eric Winer; Giuseppe Viale; David Cameron; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2010-09-28       Impact factor: 66.675

Review 6.  Mammary gland stem cells: more puzzles than explanations.

Authors:  Suneesh Kaimala; Swathi Bisana; Satish Kumar
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.

Authors:  Prema S Rao; Morgan Labhart; Susan L Mayhew; Seshadri Thirumala; U Subrahmanyeswara Rao
Journal:  Tumour Biol       Date:  2014-04-29

9.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

10.  Taxonomy of breast cancer based on normal cell phenotype predicts outcome.

Authors:  Sandro Santagata; Ankita Thakkar; Ayse Ergonul; Bin Wang; Terri Woo; Rong Hu; J Chuck Harrell; George McNamara; Matthew Schwede; Aedin C Culhane; David Kindelberger; Scott Rodig; Andrea Richardson; Stuart J Schnitt; Rulla M Tamimi; Tan A Ince
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.